NB, M., A, M., P, D., R, R., & S, G. (2019). Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations. Clinical neuropharmacology, 42(5), 149. https://doi.org/10.1097/WNF.0000000000000354
Chicago Style (17th ed.) CitationNB, Modi, Mittur A, Dinh P, Rubens R, and Gupta S. "Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations." Clinical Neuropharmacology 42, no. 5 (2019): 149. https://doi.org/10.1097/WNF.0000000000000354.
MLA (9th ed.) CitationNB, Modi, et al. "Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations." Clinical Neuropharmacology, vol. 42, no. 5, 2019, p. 149, https://doi.org/10.1097/WNF.0000000000000354.